An Interpretable Vision Transformer as a Fingerprint-Based Diagnostic Aid for Kabuki and Wiedemann-Steiner Syndromes
Marilyn Lionts, Arnhildur Tomasdottir, Viktor I. Agustsson, Yuankai Huo, Hans T. Bjornsson, Lotta M. Ellingsen
TL;DR
This study addresses the diagnostic gap for Kabuki syndrome (KS) and Wiedemann-Steiner syndrome (WSS) by leveraging dermatoglyphic signals through a vision transformer (ViT). A fingerprint dataset from KS, WSS, and controls was collected, preprocessed with quality filtering and Gabor-based enhancement, and analyzed with an ensemble ViT classifier augmented by attention heatmaps to distinguish KS, WSS, and controls, achieving AUCs up to 0.85. The results indicate syndrome-specific fingerprint features beyond persistent fetal pads and demonstrate a noninvasive, interpretable diagnostic aid that could expand access to genetic diagnostics, including potential smartphone-based capture for wider use. This work lays groundwork for dermatoglyphic AI tools in rare genetic diseases and highlights interpretability as a key component for clinical adoption.
Abstract
Kabuki syndrome (KS) and Wiedemann-Steiner syndrome (WSS) are rare but distinct developmental disorders that share overlapping clinical features, including neurodevelopmental delay, growth restriction, and persistent fetal fingertip pads. While genetic testing remains the diagnostic gold standard, many individuals with KS or WSS remain undiagnosed due to barriers in access to both genetic testing and expertise. Dermatoglyphic anomalies, despite being established hallmarks of several genetic syndromes, remain an underutilized diagnostic signal in the era of molecular testing. This study presents a vision transformer-based deep learning model that leverages fingerprint images to distinguish individuals with KS and WSS from unaffected controls and from one another. We evaluate model performance across three binary classification tasks. Across the three classification tasks, the model achieved AUC scores of 0.80 (control vs. KS), 0.73 (control vs. WSS), and 0.85 (KS vs. WSS), with corresponding F1 scores of 0.71, 0.72, and 0.83, respectively. Beyond classification, we apply attention-based visualizations to identify fingerprint regions most salient to model predictions, enhancing interpretability. Together, these findings suggest the presence of syndrome-specific fingerprint features, demonstrating the feasibility of a fingerprint-based artificial intelligence (AI) tool as a noninvasive, interpretable, and accessible future diagnostic aid for the early diagnosis of underdiagnosed genetic syndromes.
